Artes Medical, Inc.

Tissue engineering firm begins qualification of U.S. manufacturing of ArteFill

Published in Pharma Law Weekly, May 24th, 2005

Artes Medical, Inc., a privately held specialty pharmaceutical and medical device company, announced that it has begun qualification runs of its flagship product, ArteFill, at its newly completed commercial cGMP manufacturing facility in San Diego.

ArteFill is a permanent injectable wrinkle filler used to correct smile lines or naso-labial folds.

These qualification runs of ArteFill are a critical step in the final U.S. Food & Drug Administration (FDA) approval process for Artes Medical. The FDA approvable letter, received by Artes Medical in January 2004, required this milestone to be achieved in order to complete the full FDA approval...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Pharma Law Weekly

Source: Pharma Law Weekly (2005-05-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry